lead plaintiff deadline

Rosen Law Firm urges $PMI investors to join class action alleging false statements, social media misinformation, and insider share dumping. Lead plaintiff deadline: April 13, 2026.

Rosen Law Firm urges $ALIT investors to join securities class action alleging false growth statements and undisclosed dividend sustainability issues.

Rosen Law Firm alerts $COTY investors of May 22 deadline in securities lawsuit alleging false statements on growth, margins, and segment performance.

Eos Energy Enterprises faces shareholder securities class action alleging false statements about production capacity and battery performance, with May 5, 2026 deadline for investor claims.

Securities class action filed against $SLNO alleging false statements about DCCR drug safety. Investors have until May 5, 2026 deadline to join lawsuit.

Rosen Law Firm files class action against New Era Energy & Digital ($NUAI) for allegedly misrepresenting Texas data center permits and fraudulent New Mexico oil well schemes.

Rosen Law Firm urges $LU investors to join securities lawsuit alleging false statements on internal controls and financial results through January 2025.

Law firm Holzer & Holzer filed shareholder class actions against $NUAI and $GOSS for allegedly making materially false statements. Investors have until June 1, 2026 to seek lead plaintiff status.

Class action filed against $POM alleges materially false statements, social media misinformation, insider dumping, and artificial trading. Investors have until April 7, 2026 to seek lead plaintiff status.

Class action lawsuit filed against $PSFE for alleged false statements and undisclosed business risks. Stock plunged 27.6% after November guidance miss; lead plaintiff deadline April 7, 2026.

Shareholders in HTGC, PSIX, and COTY face imminent class action deadlines (May 19-22, 2026) alleging material misstatements regarding valuations, sales, and segment performance disclosures.

Law firm announces shareholder lawsuit deadlines (May 2026) against $ALIT, $GO, $GEMI over alleged materially false statements on financials, dividends, and business viability.

Law firm announces lead plaintiff deadlines for shareholder class actions against $AQST, $NKTR, and $EOSE over alleged false statements and misleading guidance.

Robbins LLP sued Aldeyra Therapeutics over alleged investor misrepresentation regarding failed drug reproxalap. FDA rejected approval; stock fell 70.7%. Lead plaintiff deadline: May 29, 2026.

Class action filed against Ostin Technology ($OST) alleging pump-and-dump fraud, with estimated investor losses exceeding $950 million from May-June 2025 trading period.

Rosen Law Firm notifies investors in $CWH securities class action alleging material misstatements on inventory management and consumer demand. Lead plaintiff deadline: May 11, 2026.

Rosen Law Firm urges $HTGC investors to join class action alleging false statements on due diligence and portfolio valuations. Lead plaintiff deadline: May 19, 2026.

Rosen Law Firm initiates securities class action against $TCOM for allegedly understating regulatory risks from monopolistic practices. May 11 deadline for investors.

Rosen Law Firm alerts $QURE investors with losses exceeding $100K to meet April 13 deadline in securities class action over alleged FDA approval status misrepresentation.

Rosen Law Firm urges Inovio investors with $100K+ losses to file by April 7 deadline in securities class action alleging false manufacturing and regulatory statements.